• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Discrepancies exist between measured and estimated glomerular filtration rate

byDavid XiangandKiera Liblik
July 18, 2022
in Chronic Disease, Nephrology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. There are significant differences between measured and estimated glomerular filtration rate (mGFR and eGFR) at the individual patient level.

2. The differences between mGFR and eGFR were small and insignificant at the population level.

Evidence Rating Level: 1 (Excellent)

Study Rundown: GFR is the standard metric for monitoring kidney function in patients. Specifically, mGFR is the gold standard for quantifying GFR in a clinical setting. However, mGFR is not practical for every patient as it requires more time and resources to determine than eGFR. Thus, estimated GFR (eGFR) is often used instead. eGFR is the predicted average mGFR based on a formula applied to large derivation cohorts. Patient values of serum creatinine, age, and sex are used. Though the average population difference between mGFR and eGFR is insignificant, there is a knowledge gap in understanding the magnitude and consequences of individual patient differences between mGFR and eGFR. The present study aimed to measure individual variations in mGFR and eGFR, and compare this to population average differences. In summary, it found that individual-level differences between mGFR and eGFR were substantial. Notably, this study was limited by unquantifiable sources of variability in the measurement of mGFR and serum markers without short-term replicates. Nevertheless, the study’s findings are significant, as they demonstrate that substantial and significant individual-level differences between mGFR and eGFR exist, and possible clinical implications must be further investigated

Click to read the study in AIM

Relevant Reading: Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate

In-Depth [cross-sectional study]: The present study was conducted based on data from four United States community-based epidemiologic cohort studies. The four cohort studies (GENOA, ECAC, ALTOLD, and CRIC) included patients with chronic kidney disease, essential hypertension, or living kidney donors. The primary outcome measures were mGFR using urinary iothalamate and plasma iohexol clearance and eGFR calculated from serum creatinine concentration alone (eGFRCR) and with cystatin C. Outcomes in the primary analysis were assessed via quantile regression models and multivariable logistic regression. Based on the primary analysis, the population level difference between mGFR and eGFR was negligible, with a median difference of -0.6 (95% Confidence Interval, -1.2 to -0.2). However, the individual-level differences between mGFR and eGFR were large and significant. With an eGFR of 60, 50% of the mGFRs ranged from 52 to 67, 80% from 45 to 76, and 95% from 36 to 87. With an eGFR of 49 to 59, 36% had an mGFR greater than 60 while 20% had an mGFR less than 45. In patients with an eGFR of 15 to 29, 30% of patients had an mGFR greater than 30 and 5% had an mGFR less than 15. Overall, this study demonstrates that significant individual-level differences exist between mGFR and eGFR, and suggests that labs reporting eGFR should also consider including the possibility of this uncertainty to quantify patient kidney function accurately.

RELATED REPORTS

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia

Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseasechronic kidney diseaseeGFRessential hypertensionGFRinternal medicinelaboratory medicineliving kidney donorsmGFRnephrologyrenal function
Previous Post

Children’s physical activity significantly decreased during the COVID-19 pandemic

Next Post

Vaccinated individuals less likely to develop SARS-CoV-2 anti-nucleocapsid antibodies post-infection

RelatedReports

Resection of colorectal liver metastases may improve cost and longevity
Chronic Disease

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

January 30, 2023
β-blockers linked to improved survival in preserved ejection fraction heart failure
Cardiology

Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia

January 27, 2023
Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia

January 27, 2023
2 Minute Medicine Rewind May 20, 2019
Chronic Disease

Chronic obstructive pulmonary disease associated with worse postoperative outcomes

January 26, 2023
Next Post
Compliance-linked incentives increase infant immunizations rates in rural India

Vaccinated individuals less likely to develop SARS-CoV-2 anti-nucleocapsid antibodies post-infection

The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor

LCAR-B38M CAR-T cell therapy promising at 4-year follow-up for treatment of refractory multiple myeloma

Novel coronavirus identified from patients with pneumonia in Wuhan, China

The majority of athletes do not suffer from serious complications following COVID-19

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options